Please login to the form below

Not currently logged in
Email:
Password:

Ipsen appoints Christel Bories as deputy CEO

Has senior experience in several industries

Ipsen Christel BoriesChristel Bories has joined French biopharma company Ipsen as its deputy CEO, effective today.

Bories (pictured right) has years of senior experience in French business, and currently holds several positions, including VP of think-tank La Fabrique de l'Industrie, chair of the strategy committee of electrical company Legrand and member of the board of directors of packaging company Smurfit Kappa and the bank Natixis.

Her main focus has been within the aluminium industry, including several years as director of strategy and management control at Pechiney.

Following the company's merger with Alcan, she then served as chair of Alcan Packaging and then chair of Alcan Engineered Products.

She also spent time as CEO of Constellium, which was created after Rio Tinto acquired Alcan and then sold off the Alcan Engineered Products business.

Marc de Garidel, chairman and CEO of Ipsen, said Bories' wide experience outside pharma would benefit the company.

“She will provide a new perspective on our activities and the group will benefit from her extensive experience both in France and internationally.

“In her various positions, Christel demonstrated strong know-how and proven effectiveness in operational management. Christel shares our values and her expertise will be valuable to accelerate Ipsen's development."

1st March 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics